Japanese Journal of Radiology

, Volume 28, Issue 8, pp 584–590 | Cite as

Application of 18F-fluorodeoxyglucose positron emission tomography to detection of proximal lesions of obstructive colorectal cancer

Original Article



In cases of obstructive colorectal cancer (CRC), preoperative diagnosis of the proximal lesion is often difficult when the primary lesion impedes the passage of the endoscope. The aim of this study was to evaluate the usefulness of fluorine-18-fluorodeoxyglucose positron emission tomography (FDG-PET) in such cases.

Materials and methods

A total of 52 obstructive CRC patients who underwent preoperative FDG-PET and subsequent surgical resection were retrospectively reviewed. The correlation between characteristics of the proximal lesion and FDG-PET findings was analyzed statistically.


There was a significant correlation between the proximal lesion size and the maximum standardized uptake value (P = 0.00016). Abnormal FDG accumulation in the proximal colon indicated the existence of proximal cancer or adenoma with a sensitivity of 50% and a specificity of 100%. There was a significant difference in the distribution of tumor size between the cases with proximal abnormal accumulation and those with no proximal accumulation (P = 0.00014). A proximal tumor of ≥8 mm can be demonstrated by an accumulation of FDG with a sensitivity of 94.1%.


FDG-PET can estimate the existence of a proximal lesion and its size. Results may contribute to decisions regarding the type of surgery in cases of obstructive CRC.

Key words

Fluorodeoxyglucose positron emission tomography (FDG-PET) Maximum standardized uptake value (SUVmax) Obstructive colorectal cancer (CRC) Diagnosis 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Li M, Gu J. Changing patterns of colorectal cancer in China over a period of 20 years. World J Gastroenterol 2005;11:4685–4688.PubMedGoogle Scholar
  2. 2.
    Oya M, Takahashi S, Okuyama T, Yamaguchi M, Ueda Y. Synchronous colorectal carcinoma: clinico-pathological features and prognosis. Jpn J Clin Oncol 2003;33:38–43.CrossRefPubMedGoogle Scholar
  3. 3.
    Cunliffe WJ, Hasleton PS, Tweedle DE, Schofield PF. Incidence of synchronous and metachronous colorectal carcinoma. Br J Surg 1984;71:941–943.CrossRefPubMedGoogle Scholar
  4. 4.
    Ekelund GR, Pihl B. Multiple carcinomas of the colon and rectum. Cancer 1974;33:1630–1634.CrossRefPubMedGoogle Scholar
  5. 5.
    Cappell MS, Friedel D. The role of sigmoidoscopy and colonoscopy in the diagnosis and management of lower gastrointestinal disorders: endoscopic findings, therapy and complications. Med Clin North Am 2002;86:1253–1288.CrossRefPubMedGoogle Scholar
  6. 6.
    Pelosi E, Deandreis D. The role of 18F-fluoro-deoxy-glucose positron emission tomography (FDG-PET) in the management of patients with colorectal cancer. Eur J Surg Oncol 2007;33:1–6.PubMedGoogle Scholar
  7. 7.
    Crippa F, Gavazzi C, Bozzetti F, Chiesa C, Pascali C, Bogni A, et al. The influence of blood glucose levels on [18F]fluorodeoxyglucose (FDG) uptake in cancer: a PET study in liver metastases from colorectal carcinomas. Tumori 1997;83:748–752.PubMedGoogle Scholar
  8. 8.
    Brullet E, Montané JM, Bombardó J, Bonfill X, Noguè M, Bordas JM. Intraoperative colonoscopy in patients with colorectal cancer. Br J Surg 1992;79:1376–1378.CrossRefPubMedGoogle Scholar
  9. 9.
    Kim MS, Park YJ. Detection and treatment of synchronous lesions in colorectal cancer: the clinical implication of perioperative colonoscopy. World J Gastroenterol 2007;13:4108–4111.PubMedGoogle Scholar
  10. 10.
    Koslin DB. Update on gastrointestinal imaging. Rev Gastroenterol Disord 2002;2:3–10.PubMedGoogle Scholar
  11. 11.
    Levin B, Lieberman DA, McFarland B, Smith RA, Brooks D, Andrews KS, et al. American Cancer Society Colorectal Cancer Advisory Group; US Multi-Society Task Force; American College of Radiology Colon Cancer Committee. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008;58:130–160.CrossRefPubMedGoogle Scholar
  12. 12.
    Liedenbaum MH, de Vries AH, van Rijn AF, Dekker HM, Willemssen FE, van Leerdam ME, et al. CT colonography with limited bowel preparation for the detection of colorectal neoplasia in an FOBT positive screening population. Abdom Imaging 2009 Nov 4. (Epub ahead of print)Google Scholar
  13. 13.
    Chaparro M, Gisbert JP, Del Campo L, Cantero J, Maté J. Accuracy of computed tomographic colonography for the detection of polyps and colorectal tumors: a systematic review and meta-analysis. Digestion 2009;80:1–17.CrossRefPubMedGoogle Scholar
  14. 14.
    Endo K, Oriuchi N, Higuchi T, Iida Y, Hanaoka H, Miyakubo M, et al. PET and PET/CT using 18F-FDG in the diagnosis and management of cancer patients. Int J Clin Oncol 2006;11:286–296.CrossRefPubMedGoogle Scholar
  15. 15.
    Nagata K, Ota Y, Okawa T, Endo S, Kudo S. PET/CT colonography for the preoperative evaluation of the colon proximal to the obstructive colorectal cancer. Dis Colon Rectum 2008;51:882–890.CrossRefPubMedGoogle Scholar
  16. 16.
    Gu J, Yamamoto H, Fukunaga H, Danno K, Takemasa I, Ikeda M, et al. Correlation of GLUT-1 overexpression, tumor size, and depth of invasion with 18F-2-fluoro-2-deoxy-d-glucose uptake by positron emission tomography in colorectal cancer. Dig Dis Sci 2006;51:2198–2205.CrossRefPubMedGoogle Scholar
  17. 17.
    Strauss LG, Klippel S, Pan L, Schönleben K, Haberkorn U, Dimitrakopoulou-Strauss A. Assessment of quantitative FDG PET data in primary colorectal tumours: which parameters are important with respect to tumour detection? Eur J Nucl Med Mol Imaging 2007;34:868–877.CrossRefPubMedGoogle Scholar
  18. 18.
    Gutman F, Alberini JL, Wartski M, Vilain D, Le Stanc E, Sarandi F, et al. Incidental colonic focal lesions detected by FDG PET/CT. AJR Am J Roentgenol 2005;185:495–500.CrossRefPubMedGoogle Scholar
  19. 19.
    Van Kouwen MC, Nagengast FM, Jansen JB, Oyen WJ, Drenth JP. 2-(18F)-fluoro-2-deoxy-d-glucose positron emission tomography detects clinical relevant adenomas of the colon: a prospective study. J Clin Oncol 2005;23:3713–3717.CrossRefPubMedGoogle Scholar
  20. 20.
    Hebertson RA, Lee ST, Tebbutt N, Scott AM. The expanding role of PET technology in the management of patients with colorectal cancer. Ann Oncol 2007;18:1774–1781.CrossRefGoogle Scholar
  21. 21.
    Engel H, Steinert H, Buck A, Berthold T, Huch Böni RA, von Schulthess GK. Whole-body PET: physiological and artifactual fluorodeoxyglucose accumulations. J Nucl Med 1996;37:441–446.PubMedGoogle Scholar
  22. 22.
    Cook GJ, Fogelman I, Maisey MN. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation. Semin Nucl Med 1996;26:308–314.CrossRefPubMedGoogle Scholar

Copyright information

© Japan Radiological Society 2010

Authors and Affiliations

  1. 1.Department of SurgeryAizawa HospitalMatsumotoJapan
  2. 2.Department of RadiologyAizawa HospitalMatsumotoJapan

Personalised recommendations